Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

about

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents.Early investigational tubulin inhibitors as novel cancer therapeutics.

P2860

Q36609596-F3061958-07DC-4CA0-9490-B23CBC8E3440 Q36941448-00577B45-80E8-49EE-BA61-658A59A28BF2 Q38836161-9CB6A001-0D87-4929-A0FA-24BE8C8A8FBB

P2860

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

Item

http://www.wikidata.org/entity/Q40227957

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

@en

type

Item

label

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

@en

prefLabel

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

@en

P1476

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

@en

P2093

Junichi Watanabe

http://www.w3.org/2001/XMLSchema#string

Motohiro Kobayashi

http://www.w3.org/2001/XMLSchema#string

Tsugitaka Natsume

http://www.w3.org/2001/XMLSchema#string

P2860

Genes expressed in human tumor endothelium

Targeting tumor vasculature with homing peptides from phage display.

Enhancement of radiation therapy by the novel vascular targeting agent ZD6126.

Phase I trial of combretastatin a-4 phosphate with carboplatin.

Vascular-targeting therapies for treatment of malignant disease.

Vascular attack as a therapeutic strategy for cancer.

Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.

ZD6126: a novel small molecule vascular targeting agent.

Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.

Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.

P304

1410-1416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2006.00330.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6794479

http://www.w3.org/2001/XMLSchema#string

P698

16999818

http://www.w3.org/2001/XMLSchema#string

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

about

P2860

P2860

Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698